27 results on '"Segurado, Oscar G."'
Search Results
2. Novel therapies for graft versus host disease with a focus on cell therapies.
3. Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia
4. BRIEF REPORT: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion
5. Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial
6. HUMIRA® Pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab
7. Genetic structure of the novel low-frequency haplotype HLA-B49,SC01,DR4 and its contribution to insulin-dependent diabetes susceptibility
8. Running out of steam
9. Spanish laboratory backs off bid to cut research staff
10. Spain expands despite financial and logistical hurdles
11. Two BF F Subtypes, but no BF S, BF F1 or BF S07 Subdivision, Are Found by Isoelectric Focusing.
12. The Multifactorial Nature of MHC-Linked Susceptibility to Insulin-Dependent Diabetes.
13. Identification of predominant T-cell receptor rearrangements by temperature-gradient gel electrophoresis and automated DNA sequencing.
14. Shared SstI RFLPs by HLA-Aw19, A23/24 and A3/11 crossreacting groups.
15. A novel diabetes-susceptibility HLA haplotype is present in the Croatian population.
16. Factor B activation in systemic lupus erythematosus.
17. C4 Chido 3 and 6 Distinguish Two Diabetogenic Haplotypes: HLA-B49,SC01,DR4,DQw8 and B8,SC01,DR3,DQw2
18. Both HLA class II and class III DNA polymorphisms are linked to juvenile rheumatoid arthritis susceptibility
19. Acquired selective signature dysgraphia.
20. New DNA sequences for the human complement gene C4
21. Autoimmunogenic HLA-DRB1 ∗0301 allele (DR3) may be distinguished at the DRB1 non-coding regions of HLA-B8,DR3,Dw24 and B18,DR3,Dw25 haplotypes
22. Restricted TCR repertoire and disease
23. Challenges and opportunities when transitioning from in vivo gene replacement to in vivo CRISPR/Cas9 therapies - a spotlight on hemophilia.
24. Hemophilia A gene therapy: current and next-generation approaches.
25. Cost-effectiveness of sequential therapy with tumor necrosis factor antagonists in early rheumatoid arthritis.
26. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.
27. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.